Design of a Clinical Event Monitor
โ Scribed by George Hripcsak; Paul D. Clayton; Robert A. Jenders; James J. Cimino; Stephen B. Johnson
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- English
- Weight
- 255 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0010-4809
No coin nor oath required. For personal study only.
โฆ Synopsis
The issues and implementation of a clinical event monitor are described. An event monitor generates messages for providers, patients, and organizations based on clinical events and patient data. For example, an order for a medication might trigger the generation of a warning about a drug interaction. A model based on the active database literature has as its main components an event (which triggers a rule to fire), a condition (which tests whether an action ought to be performed), and an action (often the generation of a message). The details of implementing such a monitor are described, using as an example the Columbia-Presbyterian Medical Center clinical event monitor, which is based on the Arden Syntax for Medical Logic Modules.
๐ SIMILAR VOLUMES
This paper presents a design for randomized clinical trials in which incomplete data are collected on the occurrence of potentially recurrent events through periodic monitoring. In particular, events are assumed to arise according to a point process, but information is available at the times of moni
In implementing a clinical event monitor (CEM), a decision-support system, we worked with an existing repository of clinical data (Keystone), fed from ancillary systems using HL7. The rules are written in the Arden Syntax, an ASTM standard for expressing medical knowledge as medical logic modules (M
Objectives ร To present a design for Prescription-Event Monitoring in Japan (J-PEM). Methods ร In J-PEM, pharmacists are asked to register patients who are prescribed the `test drug' or a `control drug' for the ยฎrst time ever, the drug, and prescribing physician. Although J-PEM does not identify all
Results from external studies often play an important role in many aspects of a clinical trial. Their incorporation into the decision making process of a trial, however, is rarely conducted in a formal manner. This conference will address what formal role, if any, meta-analytic summaries of external